GMP News is the primary publication focusing on GMP (Good Manufacturing Practice) within Russia. 

All of Solagran's substances are manufactured in accordance with strict GMP protocols. 

This extensive article published in February 2014 explores the company's production facility in Tomsk and the unique patented extraction technology that allows the creation of a range of highly therapeutic substances - "Bioeffectives".